Stem Cell Research (Jun 2023)

Generation of two human NRF2 knockout iPSC clones using CRISPR/Cas9 editing

  • Sylvia Merkert,
  • Alexandra Haase,
  • Julia Dahlmann,
  • Gudrun Göhring,
  • Fakhar H. Waqas,
  • Frank Pessler,
  • Ulrich Martin,
  • Ruth Olmer

Journal volume & issue
Vol. 69
p. 103090

Abstract

Read online

The nuclear factor erythroid 2-related factor 2 (NFE2L2, known as NRF2) regulates the expression of antioxidative and anti-inflammatory proteins. In order to investigate its impact during viral infections and testing of antiviral compounds, we applied CRISPR/Cas9 editing to eliminate NRF2 in the human iPS cell line MHHi001-A and generated two NRF2 knockout iPSC clones MHHi001-A-6 and MHHi001-A-7. After differentiation into epithelia or endothelial cells, these cells are useful tools to examine the antiviral effects of activators of the NRF2 signaling pathway.